Risk-Based Monitoring: What We've Learnt in a Year - a Large Pharma Perspective

Recorded on May 
28, 2014

In this webinar recording, learn about how Sanofi-Aventis harnessed Central Statistical monitoring techniques to improve data quality and oversight. This session showcases the impact that Sanofi has had on enhancing its technology-driven approach.

Sanofi started to investigate general issues around scientific misconduct back in 2008 with IDDI (CluePoints' parent company) and went on to implement Central Statistical Monitoring with CluePoints in 2012.

If you have any questions, please don't hesitate to contact us at contact@cluepoints.com